HHMI
K

Howard Hughes Medical Institute’s Kellanova K Stock Holding History

Howard Hughes Medical Institute’s Portfolio K Stock Details K Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58
Closed -$4.76K – 503
2025
Q3 		$4.76K Hold
58
– – ﹤0.01% 353
2025
Q2 		$4.61K Buy
+58
New +$4.74K ﹤0.01% 347
2019
Q2 		– Sell
-53,250
Closed -$2.87M – 27
2019
Q1 		$2.87M Hold
53,250
– – 0.67% 24
2018
Q4 		$2.85M Buy
+53,250
New +$3.21M 0.9% 26

Other funds holding K

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BPMC
Buckland Partners Management Co Harrison, New York $165M AUM
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
FAMI
Fideuram Asset Management (Ireland) Dublin 1 $5.26B AUM
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Howard Hughes Medical Institute's K Position: Q4 2025 in Review

Howard Hughes Medical Institute sold out of Kellanova (K) in Q4 2025, closing a stake of 58 shares — an estimated $4.76K sold.

Howard Hughes Medical Institute first reported a position in K in Q4 2018 and held it in 4 quarters. The position peaked at $2.87M in Q1 2019. 6 funds tracked by Wall St. Rank hold K as of Q4 2025.

  • Howard Hughes Medical Institute reported no remaining Kellanova position as of Q4 2025 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 58 Kellanova shares in Q4 2025, an estimated $4.76K.
  • Howard Hughes Medical Institute first reported a position in Kellanova in Q4 2018 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Kellanova position peaked at $2.87M in Q1 2019.
  • 6 funds tracked by Wall St. Rank held Kellanova as of Q4 2025.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2025, filed 17 Feb 2026.